2Crosignani P,Olive D, Bergqvist A, et al . Advances in the management of endometriosis: An update for clinicians[ J ]. Human Reproduction Update, 2006,12(2) : 179 - 189.
3Sharpe KL, Muse KN. Spontaneous and steroid - induced recurrence of endometriosis after suppression by a gonadotropin - releasing hormone agonist in the rat[J]. Am J Obstet Gynecol, 1991,164( 1 Pt 1 ) : 187 - 194.
4Meldrum DR, Chang R J, Lu J, et al. Medical oophorectomy using a long acting GnRH agonist: a possible new approach to the treatment of endometriosis[J]. J Clin Endocrinol Metab, 1982, 54(5) : 1081 - 1083.
5Corm PM, Growley WJ. Gonadotropin releasing hormone and its analogues [J] .N Engl J Med, 1991,324(2): 93- 103.
7Pierce SJ, Gazvani MR, Farguharson RG. Long- term use of gonadotropin- releasong hormone agalogs and hormone replacement therapy in the management of endometriosis : a randomized trial with a 6 - year follow up[J]. Fertil Steril,2000,74(5) : 964 - 968.
8Schlaff WD, Carson SA, Luciano A, et al. Subcutaneous injection of depot medroxyprogesterone acetate compared with Leuprolide acetate in the treatment of endometriosis - associated pain[ J ]. Fertil steril, 2006, 85 (2) :314 - 325.
9Crosignani PG, Luciano A, Ray A, et al. Subcutaneous depot medroxyprogesterone acetate versus Leuprolide acetate in the treatment of endometriosis-associated pain[J] .Hum Reprod, 2006, 21(1):248-256.
10Zupi E, Marconi D, Sbracia M, et al. Add - back therapy in the treatment of endometriosis- associated pain. Fertile steril[J], 2004, 82(5): 1303- 1308.
